Shah Nawaz Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shah Nawaz Khan has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Zhankui Sun
Shanghai Frontiers Science Center for Drug Target Identification and Drug Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China
5 shared publications - Jiahua Cui
School of Pharmacy, Gannan Medical University, Ganzhou 341000, China
4 shared publications Muhammad Kashif Zaman
Shanghai Jiao Tong University
4 shared publicationsRuining Li
Shanghai Jiao Tong University
4 shared publicationsGhulam Nabi
2 shared publicationsHazir Muhammad
2 shared publications
Latest Publications
- Open Access
- 12 September 2025
- Published by Wiley in Skin Research and Technology
- Vol. 31 (9) , e70207
Discovery of a Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening
Background: Melanin synthesis plays a crucial role in skin pigmentation, and inhibiting tyrosinase, the key enzyme in melanin production, is a primary strategy for developing skin‐lightening agents. This study investigates the tyrosinase inhibitory potential of CHP‐9, a novel cyclopeptide, and evaluates its cytotoxicity and efficacy as a cosmetic depigmenting agent.Methods: CHP‐9 was synthesized via a solid‐phase peptide synthesis strategy. The tyrosinase inhibitory activity was assessed using an enzymatic assay, while its effects on melanin content were evaluated in cultured human melanocytes. The MTT assay was performed to assess cytotoxicity across a range of CHP‐9 concentrations (0.0781–10 mg/mL). Molecular docking simulations were conducted to elucidate the interaction between CHP‐9 and human tyrosinase (PDB ID: 5M8M). Statistical analysis was performed using GraphPad Prism Software, and significance was determined via one‐way ANOVA.Results: CHP‐9 exhibited significant tyrosinase inhibition (28.57% at 1% concentration) and reduced melanin content in treated melanocytes from 30.90 ± 1.13 to 23.51 ± 1.14 µg/mL. Cytotoxicity assays confirmed CHP‐9's high biocompatibility, with cell viability exceeding 90% at concentrations up to 2.5 mg/mL. Docking studies revealed strong binding affinity between CHP‐9 and key tyrosinase residues via hydrogen bonding, supporting its inhibitory mechanism.Conclusions: CHP‐9 exhibited significant tyrosinase inhibition (28.57% at 1% concentration) and reduced melanin content in melanocytes, while maintaining over 90% cell viability at effective doses. These findings suggest that CHP‐9 is a safe and effective candidate for cosmetic skin‐lightening applications. Further research is needed to enhance formulation stability and evaluate long‐term efficacy in vivo.
- 12 September 2025
- Published by Wiley in Skin Research and Technology
- Vol. 31 (9) , e70207
Open AccessDiscovery of a Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening
Background: Melanin synthesis plays a crucial role in skin pigmentation, and inhibiting tyrosinase, the key enzyme in melanin production, is a primary strategy for developing skin‐lightening agents. This study investigates the tyrosinase inhibitory potential of CHP‐9, a novel cyclopeptide, and evaluates its cytotoxicity and efficacy as a cosmetic depigmenting agent.Methods: CHP‐9 was synthesized via a solid‐phase peptide synthesis strategy. The tyrosinase inhibitory activity was assessed using an enzymatic assay, while its effects on melanin content were evaluated in cultured human melanocytes. The MTT assay was performed to assess cytotoxicity across a range of CHP‐9 concentrations (0.0781–10 mg/mL). Molecular docking simulations were conducted to elucidate the interaction between CHP‐9 and human tyrosinase (PDB ID: 5M8M). Statistical analysis was performed using GraphPad Prism Software, and significance was determined via one‐way ANOVA.Results: CHP‐9 exhibited significant tyrosinase inhibition (28.57% at 1% concentration) and reduced melanin content in treated melanocytes from 30.90 ± 1.13 to 23.51 ± 1.14 µg/mL. Cytotoxicity assays confirmed CHP‐9's high biocompatibility, with cell viability exceeding 90% at concentrations up to 2.5 mg/mL. Docking studies revealed strong binding affinity between CHP‐9 and key tyrosinase residues via hydrogen bonding, supporting its inhibitory mechanism.Conclusions: CHP‐9 exhibited significant tyrosinase inhibition (28.57% at 1% concentration) and reduced melanin content in melanocytes, while maintaining over 90% cell viability at effective doses. These findings suggest that CHP‐9 is a safe and effective candidate for cosmetic skin‐lightening applications. Further research is needed to enhance formulation stability and evaluate long‐term efficacy in vivo.
- Open Access
- 28 February 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (3) , 350
Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects
Cancer remains a primary cause of mortality, with over 18.1 million new cases and 9.6 million deaths globally in 2018. Chemotherapy, which utilizes a spectrum of cytotoxic drugs targeting the rapidly dividing cancer cells, is a predominant treatment modality. However, the tendency of chemotherapeutics to induce drug resistance and exhibit non-specific cytotoxicity necessitates the development of new anticancer agents with heightened efficacy and minimized toxicity. In recent years, the discovery of safe and effective antibacterial/antiviral agents has also been a hot spot in medicinal chemistry. This paper comprehensively reviews the synthesis, anticancer/antibacterial/antiviral activity, and structure–activity relationships of natural 1,4-naphthoquinones and their derivatives. It highlights their potential as efficient and low-toxicity antitumor and anti-infectious drug candidates.
- 28 February 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (3) , 350
Open AccessExploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects
Cancer remains a primary cause of mortality, with over 18.1 million new cases and 9.6 million deaths globally in 2018. Chemotherapy, which utilizes a spectrum of cytotoxic drugs targeting the rapidly dividing cancer cells, is a predominant treatment modality. However, the tendency of chemotherapeutics to induce drug resistance and exhibit non-specific cytotoxicity necessitates the development of new anticancer agents with heightened efficacy and minimized toxicity. In recent years, the discovery of safe and effective antibacterial/antiviral agents has also been a hot spot in medicinal chemistry. This paper comprehensively reviews the synthesis, anticancer/antibacterial/antiviral activity, and structure–activity relationships of natural 1,4-naphthoquinones and their derivatives. It highlights their potential as efficient and low-toxicity antitumor and anti-infectious drug candidates.
- Open Access
- 17 October 2024
- Published by MDPI AG in Preprints.org
Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects
Cancer remains a primary cause of mortality, with over 18.1 million new cases and 9.6 million deaths globally in 2018. Chemotherapy, which utilizes a spectrum of cytotoxic drugs targeting rapidly dividing cancer cells, is a predominant treatment modality. However, the tendency of chemotherapeutics to induce drug resistance and exhibit non-specific cytotoxicity necessitates the development of new anticancer agents with heightened efficacy and minimized toxicity. In recent years, the discovery of safe and effective antibacterial/antiviral agents has also been a hot spot in medicinal chemistry. This paper comprehensively reviews the synthesis, anticancer/ antibacterial/antiviral activity, and structure-activity relationships of natural 1,4-naphthoquinones and their derivatives. It highlights their potential as efficient and low-toxicity anti-tumor and anti-infectious drug candidates.
- 17 October 2024
- Published by MDPI AG in Preprints.org
Open AccessExploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects
Cancer remains a primary cause of mortality, with over 18.1 million new cases and 9.6 million deaths globally in 2018. Chemotherapy, which utilizes a spectrum of cytotoxic drugs targeting rapidly dividing cancer cells, is a predominant treatment modality. However, the tendency of chemotherapeutics to induce drug resistance and exhibit non-specific cytotoxicity necessitates the development of new anticancer agents with heightened efficacy and minimized toxicity. In recent years, the discovery of safe and effective antibacterial/antiviral agents has also been a hot spot in medicinal chemistry. This paper comprehensively reviews the synthesis, anticancer/ antibacterial/antiviral activity, and structure-activity relationships of natural 1,4-naphthoquinones and their derivatives. It highlights their potential as efficient and low-toxicity anti-tumor and anti-infectious drug candidates.
- Open Access
- 15 October 2024
- Published by MDPI AG in Preprints.org
Discovery of A Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening
Melanin content significantly influences the skin-lightening effects of active ingredients, with inhibition of melanin synthesis contributing to skin-lightening effects. This study evaluates the effects of novel cyclopeptide CHP-9 as a safe and potent human tyrosinase inhibitor. CHP-9 showed a significant inhibition rate of approximately 28.57% at 1% concentration. The melanin formation assay, upon exposure to CHP-9 alone, resulted in a reduction of cellular melanin content from 30.90±1.13 μg/mL to 23.51±1.14 μg/mL. Additionally, in silico molecular docking experiments were conducted to verify the tyrosinase inhibitory activity of the cyclopeptide CHP-9 on tyrosinase and it was observed that hydrogen bonding is pivotal in the binding affinity of CHP-9 with the target enzyme in docking. These results suggest that the cyclopeptide CHP-9 may serve as a valuable bioactive compound for skin-lightening agents in cosmetics applications, specifically in reducing melanin production.
- 15 October 2024
- Published by MDPI AG in Preprints.org
Open AccessDiscovery of A Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening
Melanin content significantly influences the skin-lightening effects of active ingredients, with inhibition of melanin synthesis contributing to skin-lightening effects. This study evaluates the effects of novel cyclopeptide CHP-9 as a safe and potent human tyrosinase inhibitor. CHP-9 showed a significant inhibition rate of approximately 28.57% at 1% concentration. The melanin formation assay, upon exposure to CHP-9 alone, resulted in a reduction of cellular melanin content from 30.90±1.13 μg/mL to 23.51±1.14 μg/mL. Additionally, in silico molecular docking experiments were conducted to verify the tyrosinase inhibitory activity of the cyclopeptide CHP-9 on tyrosinase and it was observed that hydrogen bonding is pivotal in the binding affinity of CHP-9 with the target enzyme in docking. These results suggest that the cyclopeptide CHP-9 may serve as a valuable bioactive compound for skin-lightening agents in cosmetics applications, specifically in reducing melanin production.
- 7 September 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 498
A comprehensive study on the effects of annular protrusion for cavitation intensification in Venturi tubes
- 7 September 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 498
A comprehensive study on the effects of annular protrusion for cavitation intensification in Venturi tubes
- Open Access
- 30 January 2024
- Published by Wiley
Photocatalytic Decarboxylative Oxidation of Carboxylic Ac-ids Using Molecular Oxygen
Decarboxylative oxidation of carboxylic acids was developed through visible light-induced photocatalysis with molecular oxygen as green oxidant and copper as co-catalyst. This reaction worked smoothly on α-disubstituted acids and primary acids, and could be potentially used in modifications of natural products. The high efficiency of this transformation was demonstrated on over 40 substrates.
- 30 January 2024
- Published by Wiley
Open AccessPhotocatalytic Decarboxylative Oxidation of Carboxylic Ac-ids Using Molecular Oxygen
Decarboxylative oxidation of carboxylic acids was developed through visible light-induced photocatalysis with molecular oxygen as green oxidant and copper as co-catalyst. This reaction worked smoothly on α-disubstituted acids and primary acids, and could be potentially used in modifications of natural products. The high efficiency of this transformation was demonstrated on over 40 substrates.
- 20 December 2022
- Published by Elsevier in Tetrahedron Letters
- Vol. 115
Synthesis and germination activity study of novel strigolactam/strigolactone analogues
- 20 December 2022
- Published by Elsevier in Tetrahedron Letters
- Vol. 115
Synthesis and germination activity study of novel strigolactam/strigolactone analogues
- Open Access
- 18 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-12
Decarboxylative oxidation-enabled consecutive C-C bond cleavage
The selective cleavage of C-C bonds is of fundamental interest because it provides an alternative approach to traditional chemical synthesis, which is focused primarily on building up molecular complexity. However, current C-C cleavage methods provide only limited opportunities. For example, selective C(sp3)-C(sp3) bond cleavage generally relies on the use of transition-metal to open strained ring systems or iminyl and alkoxy radicals to induce β-fragmentation. Here we show that by merging photoredox catalysis with copper catalysis, we are able to employ α-trisubstituted carboxylic acids as substrates and achieve consecutive C-C bond cleavage, resulting in the scission of the inert β-CH2 group. The key transformation relies on the decarboxylative oxidation process, which could selectively generate in-situ formed alkoxy radicals and trigger consecutive C-C bond cleavage. This complicated yet interesting reaction might help the development of other methods for inert C(sp3)-C(sp3) bond cleavage.
- 18 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-12
Open AccessDecarboxylative oxidation-enabled consecutive C-C bond cleavage
The selective cleavage of C-C bonds is of fundamental interest because it provides an alternative approach to traditional chemical synthesis, which is focused primarily on building up molecular complexity. However, current C-C cleavage methods provide only limited opportunities. For example, selective C(sp3)-C(sp3) bond cleavage generally relies on the use of transition-metal to open strained ring systems or iminyl and alkoxy radicals to induce β-fragmentation. Here we show that by merging photoredox catalysis with copper catalysis, we are able to employ α-trisubstituted carboxylic acids as substrates and achieve consecutive C-C bond cleavage, resulting in the scission of the inert β-CH2 group. The key transformation relies on the decarboxylative oxidation process, which could selectively generate in-situ formed alkoxy radicals and trigger consecutive C-C bond cleavage. This complicated yet interesting reaction might help the development of other methods for inert C(sp3)-C(sp3) bond cleavage.
- Open Access
- 12 April 2022
- Published by Springer Nature in Research Square
Decarboxylative oxidation enabled consecutive C-C bond cleavage
The selective cleavage of C-C bonds is of fundamental interest because it provides an alternative approach to traditional chemical synthesis, which is focused primarily on building up molecular complexity. However, current C-C cleavage methods provide only limited opportunities. For example, selective C(sp3)-C(sp3) bond cleavage generally relies on the use of transition-metal to open strained ring systems or iminyl and alkoxy radicals to induce β-fragmentation. Here we show that by merging photoredox catalysis with copper catalysis, we are able to employ α-trisubstituted carboxylic acids as substrates and achieve consecutive C-C bond cleavage, resulting in the scission of the inert β-CH2 group. The key transformation relies on the decarboxylative oxidation process, which could selectively generate in-situ formed peroxide radicals and trigger consecutive C-C bond cleavage. This complicated yet interesting reaction might help the development of other methods for inert C(sp3)-C(sp3) bond cleavage.
- 12 April 2022
- Published by Springer Nature in Research Square
Open AccessDecarboxylative oxidation enabled consecutive C-C bond cleavage
The selective cleavage of C-C bonds is of fundamental interest because it provides an alternative approach to traditional chemical synthesis, which is focused primarily on building up molecular complexity. However, current C-C cleavage methods provide only limited opportunities. For example, selective C(sp3)-C(sp3) bond cleavage generally relies on the use of transition-metal to open strained ring systems or iminyl and alkoxy radicals to induce β-fragmentation. Here we show that by merging photoredox catalysis with copper catalysis, we are able to employ α-trisubstituted carboxylic acids as substrates and achieve consecutive C-C bond cleavage, resulting in the scission of the inert β-CH2 group. The key transformation relies on the decarboxylative oxidation process, which could selectively generate in-situ formed peroxide radicals and trigger consecutive C-C bond cleavage. This complicated yet interesting reaction might help the development of other methods for inert C(sp3)-C(sp3) bond cleavage.
- Open Access
- 18 August 2021
- Published by MedCrave Group Kft. in Journal of Analytical & Pharmaceutical Research
- Vol. 10 (4) , 151-155
A novel acyl hydrazone schiff’s bases of benzimidazole-2-thiol
A series of novel acyl hydrazone derivatives of benzimidazole-2-thiol were synthesized. The acylhydrazide was condensed with a series of aromatic substituted aldehydes to yield the tetra decylhydrazone Schiff”s bases of benzimidazole-2-thiol. The acylhydrazide was taken in methanol in round bottom flask added 2-3 drops acetic acid and refluxed on hotplate the reaction mixture was monitored with TLC. After completion of reaction the product was precipitated in ice cool water, washed and dried. The synthesized compounds were screened for different biological activities such as antimicrobial, antihistamine, neutropic, analgesic, antiprotozoal, antimalarial, antiallergic, antioxidant, anticonvulsant, anti-tubercular and have shown a good results.
- 18 August 2021
- Published by MedCrave Group Kft. in Journal of Analytical & Pharmaceutical Research
- Vol. 10 (4) , 151-155
Open AccessA novel acyl hydrazone schiff’s bases of benzimidazole-2-thiol
A series of novel acyl hydrazone derivatives of benzimidazole-2-thiol were synthesized. The acylhydrazide was condensed with a series of aromatic substituted aldehydes to yield the tetra decylhydrazone Schiff”s bases of benzimidazole-2-thiol. The acylhydrazide was taken in methanol in round bottom flask added 2-3 drops acetic acid and refluxed on hotplate the reaction mixture was monitored with TLC. After completion of reaction the product was precipitated in ice cool water, washed and dried. The synthesized compounds were screened for different biological activities such as antimicrobial, antihistamine, neutropic, analgesic, antiprotozoal, antimalarial, antiallergic, antioxidant, anticonvulsant, anti-tubercular and have shown a good results.